Allergan Finds White Knight In $66B Actavis Takeover
Allergan Inc. said Monday it would sell itself to rival drugmaker Actavis PLC for roughly $66 billion to thwart the long-running $55 billion hostile buyout campaign launched by Valeant Pharmaceuticals International...To view the full article, register now.
Already a subscriber? Click here to view full article